|
COPYRIGHT 2006 Business Wire
LEXINGTON, Mass. -- Critical Therapeutics, Inc. (NASDAQ: CRTX), a biopharmaceutical company engaged in the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, today announced that its senior management will present at the following investor conferences in March:
-- Cowen & Co. 26th Annual Health...
Read the full article for free courtesy of your local library.
|